rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

ADAR1 Capital Management, LLC

10% owner

Company insider

Files Form 4 as: 10% owner, Tenax Therapeutics; 10% owner, InMed Pharmaceuticals; 10% owner, NextCure; 10% owner, Rallybio; 10% owner, Keros Therapeutics; 10% owner, Palvella Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
83
Buys
41
Sells
0
Bought
$17.5M
Sold
$0
Companies
6
Companies where not an officer
6
First trade
9 Aug 2024
Last trade
21 Oct 2026
Last filed
21 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TENX Tenax Therapeutics10% owner · Biotechnology · last 21 Oct 202610 buys · 0 sells
INM InMed Pharmaceuticals10% owner · Biotechnology · last 19 Oct 202616 buys · 0 sells
NXTC NextCure10% owner · Biotechnology · last 31 Jul 20265 buys · 0 sells
RLYB Rallybio10% owner · Biotechnology · last 19 May 20268 buys · 0 sells
KROS Keros Therapeutics10% owner · Biotechnology · last 16 May 20250 buys · 0 sells
PVLA Palvella Therapeutics10% owner · Biotechnology · last 12 Aug 20242 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
012Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 Oct 2026filed 21 Oct 2026TENX Tenax TherapeuticsBiotechnologySEC FORM 4 Bought$551K331,979 at $1.66filing
20 Oct 2026filed 21 Oct 2026TENX Tenax TherapeuticsBiotechnologySEC FORM 4 Bought$406K254,342 at $1.60filing
19 Oct 2026filed 21 Oct 2026TENX Tenax TherapeuticsBiotechnologySEC FORM 4 Bought$507K336,528 at $1.51filing
19 Oct 2026filed 20 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$1,4341,086 at $1.32filing
16 Oct 2026filed 20 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$11 at $1.32filing
15 Oct 2026filed 15 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$1,301984 at $1.32filing
14 Oct 2026filed 15 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$11K8,021 at $1.33filing
13 Oct 2026filed 15 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$750564 at $1.33filing
8 Oct 2026filed 8 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$2,9972,256 at $1.33filing
7 Oct 2026filed 8 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$4,0513,046 at $1.33filing
6 Oct 2026filed 8 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$7,4365,601 at $1.33filing
5 Oct 2026filed 5 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$24K18,182 at $1.33filing
2 Oct 2026filed 5 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$11K8,307 at $1.33filing
1 Oct 2026filed 5 Oct 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$22K16,431 at $1.33filing
16 Sep 2026filed 16 Sep 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$11K8,340 at $1.29filing
15 Sep 2026filed 16 Sep 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$70K54,256 at $1.30filing
14 Sep 2026filed 16 Sep 2026INM InMed PharmaceuticalsBiotechnologySEC FORM 4 Bought$37K28,505 at $1.29filing
3 Sep 2026filed 8 Sep 2026TENX Tenax TherapeuticsBiotechnologySEC FORM 4 Bought$1.6M900,000 at $1.78filing
3 Sep 2026filed 8 Sep 2026TENX Tenax TherapeuticsBiotechnologySEC FORM 4 Bought$1.6M900,000 at $1.78filing
2 Sep 2026filed 2 Sep 2026TENX Tenax TherapeuticsBiotechnologySEC FORM 4 Bought$338K187,704 at $1.80filing

News

Tenax Therapeutics (NASDAQ:TENX) Stock: Insider Adar1 Capital Management, Llc Acquires 336,528 Sharesdailypolitical.com · 21 Oct 2026InMed Pharmaceuticals (NASDAQ:INM) Major Shareholder Adar1 Capital Management, Llc Buys 18,182 Shares of Company Stocktickerreport.com · 5 Oct 2026Adar1 Capital Management, Llc Purchases 54,256 Shares of InMed Pharmaceuticals (NASDAQ:INM) Stockthemarketsdaily.com · 16 Sep 2026Contrasting CorMedix (NASDAQ:CRMD) & InMed Pharmaceuticals (NASDAQ:INM)INM · themarketsdaily.com · 22 Oct 2026Tenax Therapeutics (NASDAQ:TENX) Stock: Insider Adar1 Capital Management, Llc Acquires 336,528 SharesTENX · dailypolitical.com · 21 Oct 2026Head-To-Head Analysis: Rallybio (NASDAQ:RLYB) versus NewAmsterdam Pharma (NASDAQ:NAMS)RLYB · dailypolitical.com · 14 Oct 2026

3 headlines in the last 90 days name ADAR1 Capital Management, LLC; 3 articles from the last 14 days about the 4 companies they traded most, at most three about any one of them.

Sectors

Health Care41

Buys in green, sells in red, by the company’s sector.

Related people

Paula SoteropoulosDirector · Director at Rallybio, filing Form 4 there in the last year
Helen M. BoudreauDirector · Director at Rallybio, filing Form 4 there in the last year
Robert Lorne HopfnerDirector · Director at Rallybio, filing Form 4 there in the last year
Jonathan I. LieberChief Financial Officer · Chief Financial Officer at Rallybio, filing Form 4 there in the last year
Stephen UdenChief Executive Officer · Chief Executive Officer at Rallybio, filing Form 4 there in the last year
Kathleen GoinChief Operating Officer · Also traded PVLA in the last 90 days
George M. JenkinsDirector · Also traded PVLA in the last 90 days
Declan DooganDirector · Also traded TENX in the last 90 days